Design Therapeutics
DSGN
DSGN
95 hedge funds and large institutions have $260M invested in Design Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 38 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 92 → 95 (+3)
0.26% less ownership
Funds ownership: 60.83% → 60.57% (-0.26%)
55% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 38
Holders
95
Holding in Top 10
2
Calls
$9K
Puts
$1K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$3.58M | |
| 3 | +$653K | |
| 4 |
Millennium Management
New York
|
+$518K |
| 5 |
DAM
DLD Asset Management
New York
|
+$377K |
Top Sellers
| 1 | -$4.24M | |
| 2 | -$2.65M | |
| 3 | -$2.16M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.58M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.24M |
